Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Gregoire

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Toxicology (Philadelphia, Pa.)|August 24, 2019
Cannabis intoxication after accidental ingestion in infants: urine and plasma concentrations of Δ-9-tetrahydrocannabinol (THC), THC-COOH and 11-OH-THC in 10 patientsCharles Guidet, Matthieu Gregoire, Alexiane Le Dreau, et al.
Journal of the Neurological Sciences|November 25, 2025
Impact of cerebral vasospasm therapy on nimodipine exposure in subarachnoid hemorrhage: A population pharmacokinetic studyAdrien Foucher, Matthieu Gregoire, Jérôme E Dauvergne, et al.
Clinical Pharmacology and Therapeutics|July 1, 2022
Impact of Inflammation on Midazolam Metabolism in Severe COVID-19 PatientsEdouard Charles Le Carpentier, Emmanuel Canet, Damien Masson, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2026
Population pharmacokinetics of dalbavancin: external validation, model averaging, and implications for precision dosing in prolonged therapyHamza Sayadi, Matthieu Gregoire, Yeleen Fromage, et al.
International Journal of Antimicrobial Agents|August 26, 2023
Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review PanelEric Senneville, Guillermo Cuervo, Matthieu Gregoire, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2021
CSF concentration of cefotaxime in adult patients with pneumococcal meningitis: a multicentre retrospective studyPaul Le Turnier, Najoua El Helali, Romain Guilhaumou, et al.
Antimicrobial Agents and Chemotherapy|December 10, 2025
Predicting prolonged dalbavancin exposure using machine learning: a validated strategy for individualized redosingHamza Sayadi, Matthieu Gregoire, Yeleen Fromage, et al.
Drug Metabolism Reviews|December 16, 2020
CYP1A2 and tobacco interaction: a major pharmacokinetic challenge during smoking cessationMalcolm Barrangou-Poueys-Darlas, Marylène Guerlais, Edouard-Jules Laforgue, et al.
The Pediatric Infectious Disease Journal|July 18, 2023
Safety and Efficacy of Ceftaroline in Neonates With Staphylococcal Late-onset Sepsis: A Case Series AnalysisArnaud Callies, Lise Martin-Perceval, Lise Crémet, et al.
Therapie|October 11, 2025
Digital pharmacological twins: Bridging multi-scale modelling and artificial intelligence for precision medicine: The DIGPHAT consortiumJean-Baptiste Woillard, Sébastien Benzekry, Julie Josse, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Toxicology (Philadelphia, Pa.)|August 24, 2019
Cannabis intoxication after accidental ingestion in infants: urine and plasma concentrations of Δ-9-tetrahydrocannabinol (THC), THC-COOH and 11-OH-THC in 10 patientsCharles Guidet, Matthieu Gregoire, Alexiane Le Dreau, et al.
Journal of the Neurological Sciences|November 25, 2025
Impact of cerebral vasospasm therapy on nimodipine exposure in subarachnoid hemorrhage: A population pharmacokinetic studyAdrien Foucher, Matthieu Gregoire, Jérôme E Dauvergne, et al.
Clinical Pharmacology and Therapeutics|July 1, 2022
Impact of Inflammation on Midazolam Metabolism in Severe COVID-19 PatientsEdouard Charles Le Carpentier, Emmanuel Canet, Damien Masson, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2026
Population pharmacokinetics of dalbavancin: external validation, model averaging, and implications for precision dosing in prolonged therapyHamza Sayadi, Matthieu Gregoire, Yeleen Fromage, et al.
International Journal of Antimicrobial Agents|August 26, 2023
Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review PanelEric Senneville, Guillermo Cuervo, Matthieu Gregoire, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2021
CSF concentration of cefotaxime in adult patients with pneumococcal meningitis: a multicentre retrospective studyPaul Le Turnier, Najoua El Helali, Romain Guilhaumou, et al.
Antimicrobial Agents and Chemotherapy|December 10, 2025
Predicting prolonged dalbavancin exposure using machine learning: a validated strategy for individualized redosingHamza Sayadi, Matthieu Gregoire, Yeleen Fromage, et al.
Drug Metabolism Reviews|December 16, 2020
CYP1A2 and tobacco interaction: a major pharmacokinetic challenge during smoking cessationMalcolm Barrangou-Poueys-Darlas, Marylène Guerlais, Edouard-Jules Laforgue, et al.
The Pediatric Infectious Disease Journal|July 18, 2023
Safety and Efficacy of Ceftaroline in Neonates With Staphylococcal Late-onset Sepsis: A Case Series AnalysisArnaud Callies, Lise Martin-Perceval, Lise Crémet, et al.
Therapie|October 11, 2025
Digital pharmacological twins: Bridging multi-scale modelling and artificial intelligence for precision medicine: The DIGPHAT consortiumJean-Baptiste Woillard, Sébastien Benzekry, Julie Josse, et al.
Pageof 2